Page last updated: 2024-10-24

cefuroxime and Diabetic Foot

cefuroxime has been researched along with Diabetic Foot in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Diabetic Foot: Common foot problems in persons with DIABETES MELLITUS, caused by any combination of factors such as DIABETIC NEUROPATHIES; PERIPHERAL VASCULAR DISEASES; and INFECTION. With the loss of sensation and poor circulation, injuries and infections often lead to severe foot ulceration, GANGRENE and AMPUTATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Storm, AJ1
Bouter, KP1
Diepersloot, RJ1
Banga, JD1
Beerens, RG1
Erkelens, DW1

Other Studies

1 other study available for cefuroxime and Diabetic Foot

ArticleYear
Tissue concentrations of an orally administered antibiotic in diabetic patients with foot infections.
    The Journal of antimicrobial chemotherapy, 1994, Volume: 34, Issue:3

    Topics: Administration, Oral; Bacterial Infections; Cefuroxime; Diabetic Foot; Humans; Tissue Distribution

1994